Cardiac Transplantation in the New Era
Authors:
- Abbas EmaminiaAEAbbas Emaminia
- Gregg LanierGLGregg Lanier
- Chhaya AggarwalCAChhaya Aggarwal
- Kathy A. BrownKBKathy A. Brown
- Maureen RaffaMRMaureen Raffa
- Masashi KaiMKMasashi Kai
- David SpielvogelDSDavid Spielvogel
- Ramin MalekanRMRamin Malekan
- Gilbert TangGTGilbert Tang
- Steven LansmanSLSteven Lansman
- 1 July 2015
- journal article
- review article
- Published by Wolters Kluwer Health in Cardiology in Review
- Vol. 23 (4) , 182-188
Abstract
The prevalence of heart failure continues to rise due to the aging population and longer survival of people with conditions that lead to heart failure, eg, hypertension, diabetes, and coronary artery disease. Although medical therapy has had an important impact on survival of patients and improving quality of life, heart transplantation remains the definitive therapy for patients that eventually deteriorate. Since the first successful heart transplantation in 1967, significant improvements have been made regarding donor and recipient selection, surgical techniques, and postoperative care. However, the number of potential organ donors has not changed and the growing number of patients in need for transplantation has resulted an increase in waiting list time, and the need for mechanical support. To overcome this issue, the United Network for Organ Sharing implemented an allocation system to prioritize the sickest patients on the list to receive organs. Despite the careful selection of patients, pretransplant immunological screening, and multidrug immunosuppressive regimens, acute and chronic rejections occur and potentially limit graft and patient survival. Treatment for rejection largely depends on the type of rejection, the presence of hemodynamic compromise, and time after transplantation. The limiting factor for long-term graft survival is allograft vasculopathy, an immune-mediated process causing diffuse narrowing of the coronary arteries. Percutaneous coronary intervention and coronary artery bypass surgery are often not an option for this vasculopathy due to the lack of focal lesions, and retransplantation is the only option in appropriate patients.Keywords
This publication has 107 references indexed in Scilit:
- Decreased post-transplant survival among heart transplant recipients with pre-transplant hepatitis C virus positivityThe Journal of Heart and Lung Transplantation, 2011
- The Registry of the International Society for Heart and Lung Transplantation: Fourteenth Pediatric Heart Transplantation Report—2011The Journal of Heart and Lung Transplantation, 2011
- Viral Infection Induces De Novo Lesions of Coronary Allograft Vasculopathy Through a Natural Killer Cell-Dependent PathwayAmerican Journal of Transplantation, 2009
- Long-term Outcomes of Heart Transplantation in Older RecipientsThe Journal of Heart and Lung Transplantation, 2008
- Detection of Coronary Artery Disease in Orthotopic Heart Transplant Recipients With 64-Detector Row Computed Tomography AngiographyThe Journal of Heart and Lung Transplantation, 2006
- Long-Term Results of Angioplasty Vs Stenting in Cardiac Transplant Recipients With Allograft VasculopathyThe Journal of Heart and Lung Transplantation, 2005
- Percutaneous coronary intervention versus medical therapy for coronary allograft vasculopathyThe Journal of Heart and Lung Transplantation, 2002
- Revascularization procedures in patients with transplant coronary artery diseaseEuropean Journal of Cardio-Thoracic Surgery, 1997
- Dobutamine stress echocardiography in orthotopic heart transplant recipientsJACC, 1995
- Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: The Pittsburgh experienceAmerican Heart Journal, 1993